Key Metrics of Cryo-Cell International
Revenue$31.3M▲ 3.3% YoYFY 2023
Operating income−$12.3M▼ 405.7% YoY
Net profit−$9.5M▼ 443.6% YoY
Shareholders' equity−$11.0M
Market cap$41.3MCCEL · $5.13
About Cryo-Cell International
Company details
- Website
- cryo-cell.com
- Founded
- 2022
- Listed
- NYSE: CCEL (since 2022)
Company summary
Legal nameCryo-Cell International Inc.
TickerCCEL
ExchangeNYSE
CountryUnited States
SEC CIK0000862692
Listed since2022
IndustryMisc Health and Biotechnology Services
SectorOther Industries · Discovered Companies
Websitehttp://cryo-cell.com
US market & SEC filings
CCEL · NYSE · SEC CIK 0000862692
Last price · 29 Oct 2026
$5.13
+3.33%
Market cap$41.3M
P/E—On FY 2023 diluted EPS
Volume5,319
SectorHealth CareMisc Health and Biotechnology Services
Country · IPOUnited StatesListed 2022
CCEL share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Websitehttp://cryo-cell.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.